-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Arcturus Therapeutics Holdings Inc. annual Current Federal Tax Expense (Benefit) history and growth rate from 2022 to 2023.
- Arcturus Therapeutics Holdings Inc. annual Current Federal Tax Expense (Benefit) for 2023 was $1.25M, a 11.2% increase from 2022.
Current Federal Tax Expense (Benefit), Annual (USD)
Current Federal Tax Expense (Benefit), YoY Annual Growth (%)